EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

…, D Aletaha, M Aringer, M Boers… - Annals of the …, 2017 - ard.bmj.com
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international Task …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

…, N Betteridge, JWJ Bijlsma, M Boers… - Annals of the …, 2014 - ard.bmj.com
In this article, the 2010 European League against Rheumatism (EULAR) recommendations
for the management of rheumatoid arthritis (RA) with synthetic and biological disease-…

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

…, M Aringer, J Askling, A Balsa, M Boers… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …

[HTML][HTML] Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

BJ Shea, JM Grimshaw, GA Wells, M Boers… - BMC medical research …, 2007 - Springer
Background Our objective was to develop an instrument to assess the methodological
quality of systematic reviews, building upon previous tools, empirical evidence and expert …

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

…, B White, F Wolfe, A Zink, M Boers - Arthritis & …, 2011 - Wiley Online Library
Objective Remission in rheumatoid arthritis (RA) is an increasingly attainable goal, but there
is no widely used definition of remission that is stringent but achievable and could be …

American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis

DT Felson, JJ Anderson, M Boers… - … : Official Journal of …, 1995 - Wiley Online Library
Objective. Trials of rheumatoid arthritis (RA) treatments report the average response in
multiple outcome measures for treated patients. It is more clinically relevant to test whether …

The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus

…, RA De Bie, AGH Kessels, M Boers… - Journal of clinical …, 1998 - Elsevier
Most systematic reviews rely substantially on the assessment of the methodological quality
of the individual trials. The aim of this study was to obtain consensus among experts about a …

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials

DT Felson, JJ Anderson, M Boers… - … : Official Journal of …, 1993 - Wiley Online Library
Objective. To develop a set of disease activity measures for use in rheumatoid arthritis (RA)
clinical trials, as well as to recommend specific methods for assessing each outcome …

AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews

…, E Kristjansson, J Grimshaw, DA Henry, M Boers - Journal of clinical …, 2009 - Elsevier
OBJECTIVE: Our purpose was to measure the agreement, reliability, construct validity, and
feasibility of a measurement tool to assess systematic reviews (AMSTAR). STUDY DESIGN …

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

M Boers, AC Verhoeven, HM Markusse… - The Lancet, 1997 - thelancet.com
Background The value of intensive combination therapy in early rheumatoid arthritis is
unproven. In a multicentre, double-blind, randomised trial (COBRA), we compared the …